Teva to price flat to dollars
Teva Pharmaceutical Industries is out in the market with a dual tranche euro-denominated bond. Bankers expected the deal to be priced flat to the borrower’s dollar curve.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: